Iqvia Share Price (NYSE: IQV)

$190.77

▲

2.04

(1.08%)

Last updated on August 30, 2025 at 1:29 am IST

$₹

Check the interactive Iqvia Stock chart to analyse performance

Iqvia stock performance

as on August 30, 2025 at 1:29 am IST

Today's Low:$190.20
Today's High:$192.00
$190.77
0.3%
Downside
Day's Volatility :0.94%
Upside
0.64%
52 Weeks Low:$134.65
52 Weeks High:$252.69
$190.77
29.42%
Downside
52 Weeks Volatility :46.72%
Upside
24.5%

Iqvia Stock Returns

Period	Iqvia Holdings Inc.	Sector (Health Care)	Index (Russel 2000)
3 Months	37.02%	3.6%	0.0%
6 Months	3.11%	-7.7%	0.0%
1 Year	-23.4%	-12.6%	0.0%
3 Years	-9.93%	10.2%	-4.1%

Iqvia Holdings Inc. Key Stats

Check Iqvia key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close	$188.73
Open	$190.47
Today's High	$192.0
Today's Low	$190.2
Market Capitalization	$32.4B
Today's Volume	$1.1M
52 Week High	$252.69
52 Week Low	$134.645
Revenue TTM	$15.7B
EBITDA	$2.9B
Earnings Per Share (EPS)	$6.91
PE Ratio	27.61
Profit Margin	7.88%
Quarterly Earnings Growth YOY	-0.22%
Return On Equity TTM	19.79%

Stock Returns calculator for Iqvia Stock including INR - Dollar returns

The Iqvia stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

Iqvia investment value today

Current value as on today

₹81,957

Returns

₹18,043

(-18.04%)

Returns from Iqvia Stock

₹23,327 (-23.33%)

Dollar Returns*

₹5,284 (+5.28%)

Indian investors sentiment towards Iqvia Stock

-24%

Period: Jul 31, 2025 to Aug 30, 2025. Change in 30 Days versus previous period

Search interest for Iqvia Stock from India on INDmoney has decreased by -24% in the last 30 days, reflecting a downward trend in search activity.

Indian Mutual Funds that invest in Iqvia Stock

Name	Shares Held	Change in Shares	% of Assets
Edelweiss MSCI India Domestic & World Healthcare 45 Index Fund Direct Growth	277	0.00	0.27%
Nippon India US Equity Opportunities Fund Direct Growth	15940	-4985.55	3.67%
Motilal Oswal S&P 500 Index Fund Direct Growth	1328	-8.92	0.06%

Global Institutional Holdings in Iqvia Holdings Inc.

Name
Holdings %
Ameriprise Financial Inc
0.51%

Analyst Recommendation on Iqvia Stock

Rating

Trend

Buy

76%Buy

23%Hold

0%Sell

Based on 26 Wall street analysts offering stock ratings for Iqvia(by analysts ranked 0 to 5 stars)

Iqvia Share Price Target

What analysts predicted

Upside of 12.73%

Target:

$215.05

Current:

$190.77

Iqvia share price target is $215.05, a slight Upside of 12.73% compared to current price of $190.77 as per analysts' prediction.

Iqvia Stock Insights

Price Movement
In the last 3 months, IQV stock has moved up by 35.8%
Increasing Revenue
Iqvia Holdings Inc. has shown positive revenue growth over the last two quarters. The revenue increased from $3.82 billion to $4.01 billion, resulting in an average increase of 4.7% per quarter.
Increasing Net Profit
Iqvia Holdings Inc. has shown positive performance in its net profit over the last two quarters. The net profit increased from $249.0 million to $266.0 million, reflecting an average rise of 6.4% per quarter.
IQV vs IDXX (1 yr)
In the last 1 year, Idexx Laboratories, Inc. has given 34.2% return, outperforming this stock by 58.4%
IQV vs IDXX (3 yr)
In the last 3 years, Idexx Laboratories, Inc. has given 85.8% return, outperforming this stock by 96.2%
Price to Sales
Iqvia Holdings Inc. has a Price-to-Sales Ratio of 2.2, meaning that for every $1 of sales, investors are willing to pay $2.2 for the company's stock. In comparison, Idexx Laboratories, Inc. has a much higher Price-to-Sales Ratio of 13.0, indicating that investors are willing to pay $13.0 for every $1 of sales. This suggests that Iqvia Holdings Inc. is valued lower by investors relative to its sales than Idexx Laboratories.

Iqvia Holdings Inc. Financials

Revenue

Profit

Cash Flow

Annually

Quarterly

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Revenue	$11.1B	↑ 6.49%
Net Income	$191.0M	↓ 26.25%
Net Profit Margin	1.72%	↓ 0.77%

	FY20	Y/Y Change
Revenue	$11.4B	↑ 2.44%
Net Income	$279.0M	↑ 46.07%
Net Profit Margin	2.46%	↑ 0.74%

	FY21	Y/Y Change
Revenue	$13.9B	↑ 22.14%
Net Income	$966.0M	↑ 246.24%
Net Profit Margin	6.96%	↑ 4.5%

	FY22	Y/Y Change
Revenue	$14.4B	↑ 3.86%
Net Income	$1.1B	↑ 12.94%
Net Profit Margin	7.57%	↑ 0.61%

	FY23	Y/Y Change
Revenue	$15.0B	↑ 3.98%
Net Income	$1.4B	↑ 24.47%
Net Profit Margin	9.06%	↑ 1.49%

	FY24	Y/Y Change
Revenue	$15.4B	↑ 2.81%
Net Income	$1.4B	↑ 1.1%
Net Profit Margin	8.91%	↓ 0.15%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Revenue	$3.7B	↓ 4.4%
Net Income	$288.0M	↓ 38.59%
Net Profit Margin	7.71%	↓ 4.29%

	Q2 FY24	Q/Q Change
Revenue	$3.8B	↑ 2.06%
Net Income	$363.0M	↑ 26.04%
Net Profit Margin	9.52%	↑ 1.81%

	Q3 FY24	Q/Q Change
Revenue	$3.9B	↑ 2.15%
Net Income	$285.0M	↓ 21.49%
Net Profit Margin	7.32%	↓ 2.2%

	Q4 FY24	Q/Q Change
Revenue	$4.0B	↑ 1.59%
Net Income	$437.0M	↑ 53.33%
Net Profit Margin	11.04%	↑ 3.72%

	Q1 FY25	Q/Q Change
Revenue	$3.8B	↓ 3.26%
Net Income	$249.0M	↓ 43.02%
Net Profit Margin	6.5%	↓ 4.54%

	Q2 FY25	Q/Q Change
Revenue	$4.0B	↑ 4.91%
Net Income	$266.0M	↑ 6.83%
Net Profit Margin	6.62%	↑ 0.12%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Profit	$3.8B	↑ 3.33%

	FY20	Y/Y Change
Profit	$3.9B	↑ 1.87%

	FY21	Y/Y Change
Profit	$4.6B	↑ 20.26%

	FY22	Y/Y Change
Profit	$5.0B	↑ 8.34%

	FY23	Y/Y Change
Profit	$5.2B	↑ 4.2%

	FY24	Y/Y Change
Profit	$5.4B	↑ 2.6%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Profit	$1.3B	↑ 15.96%

	Q2 FY24	Q/Q Change
Profit	$1.3B	↑ 2.55%

	Q3 FY24	Q/Q Change
Profit	$1.4B	↑ 3.92%

	Q4 FY24	Q/Q Change
Profit	$1.4B	↑ 0.0%

	Q1 FY25	Q/Q Change
Profit	$1.3B	↓ 5.81%

	Q2 FY25	Q/Q Change
Profit	$1.3B	↑ 1.93%

FY19

FY20

FY21

FY22

FY23

FY24

	FY19	Y/Y Change
Operating Cash Flow	$1.4B	↑ 13.0%
Investing Cash Flow	$-1.2B	↑ 46.91%
Financing Cash Flow	$-276.0M	↓ 38.94%

	FY20	Y/Y Change
Operating Cash Flow	$2.0B	↑ 38.25%
Investing Cash Flow	$-796.0M	↓ 33.11%
Financing Cash Flow	$-217.0M	↓ 21.38%

	FY21	Y/Y Change
Operating Cash Flow	$2.9B	↑ 50.18%
Investing Cash Flow	$-2.1B	↑ 164.2%
Financing Cash Flow	$-1.2B	↑ 469.12%

	FY22	Y/Y Change
Operating Cash Flow	$2.3B	↓ 23.18%
Investing Cash Flow	$-2.0B	↓ 4.61%
Financing Cash Flow	$-329.0M	↓ 73.36%

	FY23	Y/Y Change
Operating Cash Flow	$2.1B	↓ 4.91%
Investing Cash Flow	$-1.6B	↓ 20.09%
Financing Cash Flow	$-382.0M	↑ 16.11%

	FY24	Y/Y Change
Operating Cash Flow	$2.7B	↑ 26.38%
Investing Cash Flow	$-1.4B	↓ 9.92%
Financing Cash Flow	$-878.0M	↑ 129.84%

Q1 FY24

Q2 FY24

Q3 FY24

Q4 FY24

Q1 FY25

Q2 FY25

	Q1 FY24	Q/Q Change
Operating Cash Flow	$522.0M	↓ 30.12%
Investing Cash Flow	$-314.0M	↑ 48.11%
Financing Cash Flow	$-106.0M	↓ 74.76%

	Q2 FY24	Q/Q Change
Operating Cash Flow	$588.0M	↑ 12.64%
Investing Cash Flow	$-221.0M	↓ 29.62%
Financing Cash Flow	$-260.0M	↑ 145.28%

	Q3 FY24	Q/Q Change
Operating Cash Flow	$721.0M	↑ 22.62%
Investing Cash Flow	$-599.0M	↑ 171.04%
Financing Cash Flow	$-137.0M	↓ 47.31%

	Q4 FY24	Q/Q Change
Operating Cash Flow	$885.0M	↑ 22.75%
Investing Cash Flow	$-310.0M	↓ 48.25%
Financing Cash Flow	$-375.0M	↑ 173.72%

	Q1 FY25	Q/Q Change
Operating Cash Flow	$568.0M	↓ 35.82%
Investing Cash Flow	$-305.0M	↓ 1.61%
Financing Cash Flow	$-258.0M	↓ 31.2%

	Q2 FY25	Q/Q Change
Operating Cash Flow	$443.0M	↓ 22.01%
Investing Cash Flow	$-346.0M	↑ 13.44%
Financing Cash Flow	$145.0M	↓ 156.2%

Iqvia Technicals Summary

Sell

Neutral

Buy

Iqvia is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Iqvia Holdings Inc. Vs Peers

Returns

Ratio's

Overview

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Iqvia Holdings Inc.	4.47%	3.11%	-23.4%	-9.93%	15.42%
Agilent Technologies Inc.	10.74%	-0.51%	-9.55%	-2.51%	24.3%
Idexx Laboratories, Inc.	20.6%	47.74%	37.7%	84.56%	62.07%
Thermo Fisher Scientific, Inc.	6.38%	-5.93%	-18.77%	-10.56%	13.57%
Danaher Corp.	4.47%	0.1%	-22.08%	-24.82%	-1.19%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Iqvia Holdings Inc.	27.61	27.61	1.08	11.87	0.2	0.05	NA	33.99
Agilent Technologies Inc.	29.29	29.29	1.84	5.57	0.2	0.08	0.0	22.46
Idexx Laboratories, Inc.	53.78	53.78	4.84	12.6	0.65	0.23	NA	18.2
Thermo Fisher Scientific, Inc.	28.33	28.33	1.99	22.49	0.13	0.05	0.0	133.77
Danaher Corp.	43.68	43.68	2.06	7.77	0.07	0.04	0.01	73.1

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Iqvia Holdings Inc.	Buy	$32.4B	15.42%	27.61	7.88%
Agilent Technologies Inc.	Buy	$35.7B	24.3%	29.29	17.97%
Idexx Laboratories, Inc.	Buy	$51.8B	62.07%	53.78	24.41%
Thermo Fisher Scientific, Inc.	Buy	$184.9B	13.57%	28.33	15.24%
Danaher Corp.	Buy	$147.0B	-1.19%	43.68	14.21%

About Iqvia Holdings Inc.

IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. It has a strategic collaboration with Sarah Cannon Research Institute to enhance clinical trial processes. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is based in Durham, North Carolina.

Organization	Iqvia
Employees	90000
CEO	Mr. Ari Bousbib
Industry	Health Services

Key Management of Iqvia Holdings Inc.

Name	Title
Mr. Ari Bousbib	CEO & Chairman
Mr. Ronald E. Bruehlman	Executive VP & CFO
Mr. Eric M. Sherbet J.D.	Executive VP, General Counsel & Secretary
Mr. W. Richard Staub III	President of Research & Development Solutions
Mr. Bhavik Patel	President of Commercial Solutions - IQVIA
Mr. Jim Berkshire	Executive Vice President of Global Technology & Operations
Ms. Keriann Cherofsky	Senior VP, Corporate Controller & Chief Accounting Officer
Dr. Jeffrey A. Spaeder M.D.	Senior VP, Global Chief Medical & Scientific Officer
Kerri Joseph	SVP of Investment Relation & Treasury
Ms. Trudy Stein	Chief Human Resources Officer & Executive VP

Important FAQs about investing in IQV Stock from India :

What is Iqvia share price today?

Iqvia share price today is $190.77 as on August 30, 2025 at 1:29 am IST at the close of the market. Iqvia share today touched a day high of $192.00 and a low of $190.20.

What is the 52 week high and 52 week low for Iqvia share?

Iqvia share touched a 52 week high of $252.69 and a 52 week low of $134.65. Iqvia stock price today i.e. August 30, 2025 at 1:29 am IST is closed at $190.77, lower by 24.5% versus the 52 week high.

How to invest in Iqvia Stock (IQV) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Iqvia on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Iqvia Shares that will get you 0.0079 shares as per Iqvia share price of $190.77 per share as on August 30, 2025 at 1:29 am IST.

What is the minimum amount required to buy Iqvia Stock (IQV) from India?

Indian investors can start investing in Iqvia (IQV) shares with as little as ₹88.286 or $1 (as of August 31, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹882.86 in Iqvia stock (as per the Rupee-Dollar exchange rate as on August 31, 2025). Based on Iqvia share’s latest price of $190.77 as on August 30, 2025 at 1:29 am IST, you will get 0.0524 shares of Iqvia. Learn more about fractional shares .

What are the returns that Iqvia has given to Indian investors in the last 5 years?

Iqvia stock has given 15.42% share price returns and 20.51% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?